Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$7.89 - $12.48 $5,262 - $8,324
-667 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$9.82 - $12.44 $40,959 - $51,887
-4,171 Reduced 86.21%
667 $8,000
Q3 2021

Nov 12, 2021

BUY
$8.74 - $11.84 $40,238 - $54,511
4,604 Added 1967.52%
4,838 $46,000
Q2 2021

Aug 16, 2021

BUY
$8.71 - $10.72 $2,038 - $2,508
234 New
234 $2,000

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.53B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Dark Forest Capital Management LP Portfolio

Follow Dark Forest Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Dark Forest Capital Management LP with notifications on news.